Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety The Omicron-specific Pfizer vaccine is about to start its clinical trials. The drugmaker aims to enroll more than 1,400 participants. by Griffin Davis